Clinical Research Studies

Florida Orthopaedic Associates is committed to offering our patients the latest developments in medicine, while at the same time providing our patients with the highest quality of patient care. One of the ways we accomplish this goal is through clinical trials offered through Florida Research Associates, LLC. Clinical trials, after all, are at the heart of all medical advances.

Below is a list of our current enrolling studies. Talk with your doctor, or ask to speak with Diane Martin, Clinical Research Manager and Coordinator at 386-734-3710, about volunteering to participate in a clinical trial.

Principal Investigator – Mark Hollmann, MD

Sub-Investigator – Henry Samsoe, RPA-C

Clinical Research Manager and Coordinator – Diane Martin, RN

A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee System

Protocol: CR17-003

Phase: Post-Market

Device: Truliant Knee System

Sponsor: Exactech, Inc.

Description: Ten-year study to evaluate change from pre-operative baseline to post-operative TKA functional performance in patients who receive the Truliant Knee Implant System.

Stipend Provided to Patient: Yes

Multi-Center Clinical Evaluation of the ATTUNE Revision System in Complex Primary Total Knee Arthroplasty

Protocol: DSJ-2016-03

Device: ATTUNE Revision TKA FB (fixed bearing) and RP (rotating platform) Tibial Platform with PS (posterior stabilized) Femoral Component

Sponsor: Medical Device Business Services, Inc.

Description: Five year study to evaluate change from pre-operative baseline to post-operative TKA functional performance in patients who have degrees of complexity that require the use of one or more ATTUNE revision components, typically to manage existing deformities, ligamentous deficiencies and bone loss.

Stipend Provided to Patient: Yes

A Randomized, Non-Inferiority, Phase 3, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women with Osteoporosis

Protocol: BA058-05-021

Phase: 3

Study Medication: Abaloparatide-sMTS

Sponsor: Radius Health, Inc (RADIUS)

Description: Sixteen-month open label study to evaluate a comparison of abaloparatide-sMTS, a transdermal application to the thigh daily for 5 minutes, to abaloparatide-subcutaneous, an injection administered in the abdomen daily, for the treatment in postmenopausal women with osteoporosis.

Stipend Provided to Patient: Yes